Advaxis India Cervix Cancer Trial Begins Dosing

Advaxis, Inc. … has begun dosing patients in its 110 patient clinical trial of ADXS11-001 for the treatment of cervix cancer in women for whom cytotoxic treatment has failed.
StreetInsider